tirzepatide lawsuit FDA's decision creates uncertainty for patients—and leads to a LATEST UPDATE! Tirzepatide compounding! Lawsuit!

The diabetes drug liraglutide prevents degenerative processes in a mouse model of alzheimers disease

C-met binding was examined at two HGF-doses (250 ng/ml and 500 ng/ml in PBS) by sandwich ELISA-like assay on recombinant c-met-Fc chimera as in Figure 1e, and significant changes in optical absorbance subtracted by a baseline level (negative control without HGF, bar 1 ) were depicted in Figure 2a (left column)

Seven (9.3%) were obese and changed category to overweight, and 2 (2.7%) were overweight and changed category to normal BMI

GLP-1 drugs show real promise in supporting brain health, especially in people with metabolic diseasebut they are not yet a guarantee against dementia